Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:27:57.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the comparison of safety and efficacy between risankizumab and methotrexate in participants with moderate to severe plaque psoriasis.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:08.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the diagnosis and conditions required for inclusion in the study, as well as exclusion criteria and general information about clinical research.
    Difference
    16%
    Check dated 2024-05-22T21:03:47.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:54:45.000Z thumbnail image

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.